PARTNERING

Partnering
through the
science of
ideation.

Pharmaceutical companies face growing pains when looking to rapidly expand availability of life-saving medicines. The careful and conservative deployment of financial resources globally requires both geographic expertise, market analytics and a field presence with considerable know-how. The learning curve can lead to needless delays in the launch of novel life saving drugs.

This is where IDEOGEN is your partner.

Our mission is to provide you with the commercial capabilities that are relevant to your regional objectives. We facilitate seamless access to transformative medicines for people with serious diseases and unmet medical needs.
WHAT MAKES US DIFFERENT

Specialty

CURIOUS, CREATIVE, COMPLIANT

INSIGHTS
Our company is built on a sound foundation of scientific curiosity. Our medical, regulatory and market access teams are sincerely creative in meeting the challenges of therapies for unmet medical needs. To-date we have launched 80+ Healthcare therapies across multiple geographies as both licensed and un-licensed medicines in order to grow in order to improve compliant access to innovative specialty drugs of therapeutic solutions for specialty diseases.

Speed

IMMEDIATE, INTERNATIONAL, INITIATIVE
INSIGHTS
Managed Access and/or Name Patient Programs are an example of how we bring the treatments to patients immediately prior to having a product approved in a given territory. Where possible, drugs we license or distribute are always assessed for possible early access opportunities for patients internationally. To-date we have successfully provided 1Mn+ patients with lifesaving and cost effective medicines for specialty diseases with our own initiative.

SIMPLICITY

STRUCTURED, STRAIGHTFORWARD, SIMPLE
INSIGHTS
We take pride in keeping things structured and straightforward, from the assessment of new products through licensed supply. Our interdisciplinary approach is aligned connecting lose-ends and simplifying answers to the core. This results in a win-win scenario for all players, whether they be partners, physicians, or patients.
PARTNERSHIP STRUCTURES
At Ideogen we tailor commercial engagements to best-serve the needs of all partners while keeping the need of patients as our core objective. No two products are alike and each lifecycle scenario requires bespoke attention.

Our goal is to provide our partners with complete solutions, from unlicensed through licensed medicines across multiple specialty therapy areas.

Ideogen has vested engagement with partnership types covering:
WE COVER
  • Licensing Agreements
  • Exclusive & Non-Exclusive Distribution Agreements
  • Tech Transfer Acquistion & Licensing Agreements
  • Exclusive API Trade and Representation
  • Joint Venture Partnerships
WE COVER
  • Exclusive and Semi-Exclusive Marketing & Co-Marketing Agreements
  • Exclusive Managed Access and Name Patient Programs
  • Research & Development Funding and Investments
  • Technical Co-Development Partnerships
THERAPY AREA EXPERIENCE
The implementation of IDEOGEN therapy alternatives involves a multidisciplinary approach. To develop solutions and addressing the often-complicated medical, regulatory and market access challenges around specialty medicines we have an experienced team is in place.


The in-depth expertise we offer having launched therapies with a diverse spectrum of multidisciplinary indications allows us to share a fresh state-of-the-art perspective on well established guidelines and global clinical standards.

We create bridges between therapy areas to define value creation for the needs of healthcare providers and patients alike.

MULTIDICIPLINARY FOCUS

Oncology
Hematology
Hepatology
Pulmonary
Infectious Disease
Neurology
CNS
Opthalmology
Metabolism Disorder
Immunology

DISEASE EXPOSURE

Special Access Programs

An UNMET NEED is an URGENT NEED

The reality is that progress moves at the speed of global regulations and not always at the speed of life. We believe access to life saving drugs is a basic human right that requires immediate and urgent attention. This is why we engage in name patient programs, early access projects and fulfilling global shortages of necessary medicines.
  • Global Medical Shortages
  • Name Patient Programs
  • Early Access / Compassionate Use
  • Managed Access Programs
We make it our mission to speed up access to treatments for patients as the right way to contribute to a healthier and humane society. Ideogen has a special skill set as a flexible organization that solves challenges quickly and creatively. We match real needs of patients today with immediate solutions prior to regulatory approvals.

Inquire about a medicine